Physician profile
Ilsa Leon
NPI 1932498185
$1,653.29
in general payments reported to CMS, 2019-2025
27 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $141 · 2021: $212 · 2022: $271 · 2023: $245 · 2024: $165 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $267.78 | 2019-2023 | |
| Evofem Biosciences, INC. | $202.26 | 2021-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $184.72 | 2019-2025 | |
| Hologic Sales and Service, LLC | $134.79 | 2021-2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $125.68 | 2019-2025 | |
| Astellas Pharma US INC | $120.30 | 2023-2025 | Veozah |
| Amgen INC. | $106.92 | 2019-2022 | |
| Organon LLC | $74.17 | 2022-2025 | Nexplanon, Jada System |
| Mylan Pharmaceuticals INC. | $62.56 | 2019-2022 | |
| Daiichi Sankyo INC. | $54.52 | 2025 | Injectafer |
| Medtronic, INC. | $33.56 | 2025 | Truclear |
| Biom'Up France Sas | $29.83 | 2020 | |
| Lupin INC. | $24.28 | 2019 | |
| Becton, Dickinson and Company | $24.21 | 2025 | Bd Max System, Bd Max Instrument |
| American Regent | $22.30 | 2025 | Injectafer |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22.25 | 2023 | Stravix Pl |
| Agile Therapeutics, INC. | $21.10 | 2023 | Twirla |
| Exact Sciences Corporation | $19.78 | 2023 | Cologuard Collection Kit |
| Shield Therapeutics INC | $15.60 | 2024 | |
| Roche Diagnostics Corporation | $14.70 | 2019 | |
| Meditrina | $14.21 | 2025 | |
| Merck Sharp & Dohme LLC | $13.44 | 2020 | |
| Glaxosmithkline, LLC. | $13.37 | 2023 | Arexvy, Shingrix |
| Coopersurgical, INC. | $13.15 | 2020 | |
| Minerva Surgical, INC | $13.02 | 2019 | |
| Therapeuticsmd, INC. | $12.97 | 2020 | |
| Mayne Pharma Commercial LLC | $11.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilsa Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.